Skip to content

Pharminent

cropped-ChatGPT-Image-Jun-22-2026-05_46_48-PM.png
Primary Menu
  • Home
  • Signal News
  • Biopharma Brief
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Regulatory Interactive Calendar
    • Manufacturing Intelligence
  • Contact
Light/Dark Button
Brief
  • Home
  • M&A / Deals
  • Arna Pharma and Slate Run complete JV for new US company
  • M&A / Deals

Arna Pharma and Slate Run complete JV for new US company

Pharmaceutical Business Review

The companies are also launching their first collaboratively developed product, Aridol, and plan to introduce further branded products in the future.

Read full story

pharminent May 15, 2026 (Last updated: May 21, 2026)

Pharmaceutical Business Review

The companies are also launching their first collaboratively developed product, Aridol, and plan to introduce further branded products in the future.

Read full story

Sign up to receive free daily digest

Check your inbox or spam folder to confirm your subscription.

Post navigation

Previous: Anthropic joins Gates Foundation on $200m health AI pledge
Next: Genmab drops 2 antibody assets, including another ProfoundBio ADC

Related Stories

  • M&A / Deals

AbbVie climbs post-Allergan M&A peak with Apogee buy

pharminent June 22, 2026
  • M&A / Deals

Lilly bets up to $800M for BioArctic’s brain delivery tech

pharminent June 22, 2026
  • M&A / Deals

Insilico and SK Bio forge $2.5bn AI neuroimmunity alliance

pharminent June 22, 2026

You May Have Missed

  • News

pharminent June 22, 2026
sample_feature_2026-06-22
  • News

AbbVie to Acquire Apogee Therapeutics for Nearly $11 Billion in Immunology Bet

pharminent June 22, 2026
  • M&A / Deals

AbbVie climbs post-Allergan M&A peak with Apogee buy

pharminent June 22, 2026
  • M&A / Deals

Lilly bets up to $800M for BioArctic’s brain delivery tech

pharminent June 22, 2026
© 2026 All rights reserved. | ReviewNews by AF themes.